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Abstract. Rapid diagnostic tests (RDTs) are widely used for malaria diagnosis, but lack of quality control at point
of care restricts trust in test results. Prototype positive control wells (PCW) containing recombinant malaria antigens
have been developed to identify poor-quality RDT lots. This study assessed community and facility health workers’
(HW) ability to use PCWs to detect degraded RDTs, the impact of PCW availability on RDT use and prescribing, and
preferred strategies for implementation in Lao People’s Democratic Republic (Laos) and Uganda. A total of 557 HWs
participated in Laos (267) and Uganda (290). After training, most (88% to ≥ 99%) participants correctly performed
the six key individual PCW steps; performance was generally maintained during the 6-month study period. Nearly all
(97%) reported a correct action based on PCW use at routine work sites. In Uganda, where data for 127,775 individ-
ual patients were available, PCW introduction in health facilities was followed by a decrease in antimalarial prescrib-
ing for RDT-negative patients ≥ 5 years of age (4.7–1.9%); among community-based HWs, the decrease was 12.2%
(P < 0.05) for all patients. Qualitative data revealed PCWs as a way to confirm RDT quality and restore confidence in
RDT results. HWs in malaria-endemic areas are able to use prototype PCWs for quality control of malaria RDTs.
PCW availability can improve HWs’ confidence in RDT results, and benefit malaria diagnostic programs. Lessons
learned from this study may be valuable for introduction of other point-of-care diagnostic and quality-control tools.
Future work should evaluate longer term impacts of PCWs on patient management.
INTRODUCTION
Rapid diagnostic tests (RDTs) are now widely used for
malaria diagnosis, consistent with World Health Organiza-
tion (WHO) recommendations for areas where good-quality
malaria microscopy is not available, including peripheral
health facilities and community-based fever management
programs.1,2 The need for stable, high-performing RDTs,
especially under transport and storage conditions typical in
malaria-endemic regions, has received considerable atten-
tion.3–5 RDT lot-to-lot variation and susceptibility to deteriora-
tion upon exposure to high temperatures and humidity in
supply chains have been documented.6,7 In addition, some
reports attribute health workers’ poor adherence to RDT
results at least in part to lack of confidence in test results.8,9
To maintain confidence in RDTs and optimize their utility, the
tests must demonstrate consistently reliable results. How-
ever, RDT quality control, after field deployment, is currently
difficult to implement in routine health-care contexts.10–12
A global program supports quality assurance activities for
malaria RDTs through independent laboratory-based assess-
ment of commercially available products manufactured under
ISO13485, lot verification of procured RDTs, and provision of
training materials.13 Positive control wells (PCWs) have been
proposed as point-of-care quality-control tools, as a third
component of a tiered quality assurance program.14–17 Pro-
totype PCWs have been developed as single-use plastic
wells containing small amounts of recombinant malaria par-
asite antigens targeted by commercially available RDTs.
When reconstituted with water and applied to a good-quality
RDT, the antigen solution produces a positive reaction on the
RDT. PCWs can therefore be used to test stocks of RDTs
stored and used at health facilities, to ensure their validity.
PCWs may also be used to monitor RDT quality along the
supply chain.
The study described here is part of a step-wise approach
to collect evidence to guide rational implementation strate-
gies for PCWs. The present study was designed to deter-
mine whether health workers in malaria-endemic settings
can use PCWs correctly to detect RDTs with inadequate
sensitivity after a half-day training, to assess the impact of
PCW availability on RDT use, and to gather information on
health workers’ perceptions of PCWs and preferred strate-
gies for routine use in public health-care sectors.
METHODS
Ethics and protocol. All participating health workers pro-
vided written informed consent. Before participant recruit-
ment, the study protocol was approved by the National
Ethics Committee for Health Research, Lao People’s Demo-
cratic Republic (Laos) (NECHR 009/2012); Oxford Tropical
Research Ethics Committee of the University of Oxford,
United Kingdom (1000-13); Vector Control Division Ethical
Committee of the Uganda Ministry of Health (VCD-IRC/038);
Uganda National Council for Science and Technology (HS
1271); and Research Ethics Review Committee of the World
Health Organization (protocol ID RPC545).
*Address correspondence to Daniel J. Kyabayinze, Foundation for
Innovative New Diagnostics (FIND), Kampala, Uganda. E-mails:
daniel.kyabayinze@finddx.org or drdjkyabayinze@yahoo.com
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Study sites and setting. The study was conducted from
March to October 2013 in Salavan Province, southern Laos,
and in Kiboga District, west-central Uganda. Study area
selection criteria were malaria RDTs meeting WHO procure-
ment criteria18 already in routine use in clinical care according
to plans/programs approved by the national malaria control
authorities, representative sites in Africa and Asia, and local
collaborators experienced in the conduct of operational
research on malaria diagnosis.
Malaria transmission in Salavan Province is highly sea-
sonal, typically beginning around June and peaking during
and after the annual rainy season (Lao Center of Malariol-
ogy, Parasitology and Entomology [CMPE], unpublished
data). Malaria transmission in Kiboga District is moderately
high year round (proportion of malaria blood slides positive
in fever cases was 40–60% [Uganda Ministry of Health,
unpublished data]). Before the study started, 65–95% of fever
patients were RDT negative in southern Laos, depending on
season, whereas 40–60% of fever cases were RDT nega-
tive in midwestern Uganda. The study was conducted at
government-sponsored health facilities and at community or
village health volunteers’ work stations where RDTs are used
in routine patient care.
In addition, to assess the impact of PCW availability on
RDT use, in each country, routine clinical data from a neigh-
boring “control” area with similar climate, malaria epidemiol-
ogy, health-care infrastructure, and RDT access but without
PCWs (Sekong Province in Laos; Kyankwanzi District in
Uganda) were obtained as aggregate summaries from the
Ministry of Health (Laos) or from individual health facility
and community worker logbooks (Uganda).
RDTs used in this study were provided through routine
procurement and distribution mechanisms in each country. In
Laos, RDTs are provided to government health facilities and
village health volunteers by CMPE, Lao Ministry of Health.
The RDTs in use at the time of this study were SD Bioline
Malaria Antigen Pf/Pv (Standard Diagnostics, Youngin-si,
Gyeonggi-do, Republic of Korea) (catalogue no. 05FK80, lot
082171). In Uganda, RDTs were provided in the study area
by a project led by the Malaria Consortium. The RDTs in use
at the time of this study were SD Bioline Malaria Antigen Pf
(catalogue no. 05FK50, lot 082140). Before study activities
began, RDTs from each study area passed lot testing at
WHO and Foundation for Innovative New Diagnostics (WHO-
FIND)–recognized lot testing laboratories.19
Study population. Basic health care in the study areas is
provided by staff of health facilities (“clinic staff” in this report),
typically nursing and clinical staff with < 2–3 years of formal
training; and by village or community health volunteers (“com-
munity workers”), literate or semiliterate volunteers with a few
weeks’ training who work at or near their own home. The term
“health worker” is used here to include both clinic staff and
community workers. Within the study areas, health workers
were invited to participate if their work place met these selec-
tion criteria: established use of RDTs in routine clinical work
as the only parasite-based malaria diagnostic method (i.e., no
microscopy capacity); at least five patients seen per month;
and availability of records or logbook with data on RDT use,
patient diagnoses, and treatments.
Sample size. A sample size of approximately 300 health
workers in each of the two study areas was targeted to par-
ticipate and receive PCWs. The goal was to include a repre-
sentative sample of health workers who use malaria RDTs in
routine practice, with recruitment of approximately 225 com-
munity workers in each country and the remainder being
clinic staff. The target sample size represented approximately
3–5% of the community workers using RDTs in each country.
Prototype PCW. The prototype PCW used was developed
by FIND, Geneva, Switzerland, in partnership with ReaMetrix
Inc., Bangalore, India. The product specifications of the PCW
were single-use, disposable, free-standing individual tube
containing dried recombinant antigens, synthetic variants of
the malaria parasite antigens targeted by commercially avail-
able RDTs, that is, histidine-rich protein 2, parasite lactate
dehydrogenase, and aldolase (Figure 1). The PCW contained
a sufficient concentration of each antigen to produce a test line
on a well-performing RDT, whereas failing to produce a line on
an RDT that has deteriorated to a point unreliable for detec-
tion of clinically significant parasitemia (∼200 parasites/μL).20
To perform a PCW, antigens were reconstituted by adding
100 μL of water (e.g., handwashing water) to the tube and
stirring for 2 minutes using a squeezable pipette packaged
with the PCW (see pictorial guide, Supplemental online mate-
rial). The desired amount of PCW solution, that is, 5 μL, was
placed in the RDT sample well using the transfer device
packaged with the RDT, and RDT buffer was added. The
wicking speed along the nitrocellulose strip was similar to
lysed blood and the test results were read according to RDT
instructions. PCWs were stored in their original packaging at
ambient temperature at the local offices/laboratories of
collaborating research organizations in each country before
study activities began, and at health worker work sites and
homes during the study.
PCW training and study initiation. All training and data
collection tools are in the Supplemental online material. An
initial 1-week pilot assessment preceded the study, during
which a pictorial guide (job aid) for PCW interpretation was
developed for use in both Uganda and Laos. PCWs were
introduced to participating health workers with a standard-
ized half-day training package presented by members of
the study team, who were individuals with laboratory and/or
FIGURE 1. Prototype positive control well (PCW) for malaria rapid
diagnostic tests.
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clinical background and with prior experience in clinical
malaria research and/or program implementation. Trainings
were typically held for groups of 12–20 health workers at a
central point in each subregion within the study areas. No
training in RDT use or fever case management was pro-
vided as part of this study.
After the training and initial assessment, PCWs were given
to each participating health worker, along with forms for
recording PCW use. Health workers were not given specific
guidance on when or how frequently to use PCWs; they were
told that they could use a PCW whenever they felt it was
appropriate. Health workers were provided with phone num-
bers of study staff and encouraged to call with questions,
especially if a negative or invalid RDT result was obtained
with a PCW during routine use. Study staff returned calls so
that there was no cost to health workers.
Assessment of health workers’ performance, interpre-
tation, and use of PCWs. After the initial training, health
workers’ ability to correctly use PCWs was assessed using
three approaches at three time points: immediately after
training, at the study midpoint about 3 months later, and at
the end of the study 6 months after training (Figure 2). First,
the study team used a standardized checklist to observe and
score individual participants on PCW performance and result
interpretation. Health workers had free access to the PCW
job aid, and any mistakes or questions were addressed after
the health worker had completed all steps, to avoid biasing
the assessment. Second, at the study midpoint and endpoint,
each health worker was individually presented with panels of
reacted RDTs and asked to propose the correct actions if
they obtained these results with a PCW. Third, the forms
completed by health workers during their routine work over
the study period were retrieved to determine: 1) frequency
of use of PCWs, 2) results of RDTs tested with PCWs,
3) interpretation of results, and 4) any actions taken.
Assessment of impact of PCW availability on RDT
use. In Laos, aggregated data on RDT use, results, and
treatments prescribed were obtained through CMPE from
Salavan Province, and from neighboring Sekong Province
(control). Logbook data, handwritten by health workers, were
transferred to the central level for computerized data entry.
CMPE provided summary data from the 6-month study
period and from the 3 months preceding it.
In Uganda, patient-level data were obtained from participat-
ing health facilities and community workers in Kiboga District
and from neighboring Kyankwanzi District (control). Logbook
data from the study period and the preceding 3 months, hand-
written by health workers, were transferred to district level for
routine reporting and filing and entered into a computerized
database. Data retrieved included patient age, gender, RDT
result (if done), diagnosis made, and treatment prescribed.
Assessment of health workers’ perceptions of PCWs. At
the end of the 6-month study period, focus group discussions
(FGDs) and individual semistructured interviews were held to
gather qualitative information on health workers’ experiences
with and perceptions of PCWs. Health workers were purpo-
sively selected for participation to achieve representation from
clinic staff and community workers, geographical subregions
within the study areas, demographic features, and a range
of observed abilities to correctly use PCWs. Discussions
followed topic guides developed for this purpose (Supplemen-
tal online material), and were conducted in local languages.
FIGURE 2. Study flow diagram. Study activities and data collection: In each of the two study areas, one province in Lao People’s Democratic
Republic and one district in Uganda, a target sample of approximately 300 health workers was recruited to participate in the study. Participants
were trained in positive control well (PCW) use, and supplies of PCWs were left at each work site. Data collection continued for 6 months after
the introduction of PCWs. Routine clinical and rapid diagnostic test (RDT) use data from a neighboring area in each country, without PCWs,
were retrieved as a comparison.
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Data management and statistical analysis. Quantitative
data were double entered using Microsoft Office Excel 2007
(Microsoft, Redmond, WA) in Laos and EpiData (EpiData
Association, Odense, Denmark) in Uganda. Stata version 9
(StataCorp, College Station, TX), and SPSS version 23 (IBM
Corporation, New York City, NY) were used for quantitative
data analysis. Training outcomes were presented as propor-
tions and frequencies. Comparisons between groups were
made using Pearson’s χ2 or Fisher’s exact test, whereas
changes in performance between assessments were assessed
using either McNemar or McNemar–Bowker test. Binary logis-
tic regression was used to assess the association between
age and amount of time the participant had been using RDTs
on correctly preparing individual PCW steps and interpreting
RDT results. Poisson regression was used to assess the asso-
ciation between age, facility, and PCW use on the proportions
of patients tested by RDT, positive by RDT, and RDT-positive
patients treated with an antimalarial. Estimated marginal
means, along with the 95% confidence intervals (CIs), were
calculated by the statistical software and used to illustrate
the proportion of patients tested by RDT, positive by RDT,
and RDT-positive patients treated with an antimalarial, after
adjusting for significant confounders.
For qualitative data, FGD and interview audio files were
transcribed into text files and translated into English. Analysis
was performed with NVIVO QDA Mac Beta 2014 software
(QSR International, Melbourne, Australia) to group key find-
ings into themes and subthemes using content analysis.21
Themes that emerged from the data were categorized around
local concepts of quality control and quality assurance.
RESULTS
A total of 267 health workers were enrolled in the study in
Laos, and 290 in Uganda (Table 1). The majority were com-
munity workers (72% in Laos, 83% in Uganda), with the
remainder being facility-based clinical or laboratory staff.
Assessment of health workers’ performance, interpre-
tation, and use of PCWs. Observed performance of
PCWs. Table 2 summarizes health workers’ performance of
PCWs as observed by study staff using the standardized
checklist. The majority (88% to ≥ 99%) of participants cor-
rectly performed the six key individual PCW steps. Steps
that appeared challenging for some participants included
filling the PCW dropper with the correct amount of water,
mixing the PCW solution for 120 seconds by counting or
using a timer, and transferring a single drop of PCW solution
to the correct RDT well. Observers’ notes (not shown) indi-
cated that apparently poor eyesight, and in some cases,
limited finger dexterity, contributed to some health workers’
difficulties with the dropper; errors included filling the drop-
per with water to either above or below the indicator mark.
Errors in mixing included stirring both for too short a time
and for too long. Common errors in transferring solution to
the RDT included struggling or failing to collect a drop of
solution from the PCW tube with the RDT transfer device, or
adding more than one drop of solution; in the latter case,
some participants mentioned that this was intentional, as
they had noticed that adding more solution gave a stronger
RDT test line.
When all six key steps in the PCW preparation procedure
were considered together, the proportion of participants
completing all steps correctly ranged from 62% to 93%.
When errors were made, the majority (67–79%) of partici-
pants made only one error in the six steps, but the incorrect
step varied between participants. In both study areas, the
lowest composite performance occurred at the study mid-
point (Table 2).
The proportion of health workers who correctly performed
all six key PCW steps was not influenced by whether the
TABLE 1
Participating health workers: enrolment population and descriptive data
Feature
Lao People’s Democratic Republic
Number (%) unless otherwise indicated
Uganda Number (%) unless
otherwise indicated
No. of participants enrolled 267 290
Age in years: median, interquartile range, range 36, 28–45, 17–73 40, 32–47, 22–69
Female gender 57 (21) 151 (52)
Male gender 210 (79) 139 (48)
Professional category
Community workers 192 (72) 240 (83)
Clinic staff 75 (28) 50 (17)
Highest educational level achieved*
Any primary school 118 (45) 125 †(43)
Any secondary school 125 (48) 128 (44)
Laos: Diploma/Uganda: Tertiary or University 20 (8) 37 (13)
Formally trained in RDT use 237/265 (89) 277 (96)
If trained, approximate no. of months ago‡: median, interquartile range, range 24, 12–48, 1–120 33, 24–34, 1–60
Has used RDTs in routine patient care 251/264 (95) 288 (99)
If RDTs used, approximate no. of months used§: median, interquartile range, range 36, 15–48, 1–120 32, 24–34, 1–60
Participation—no. of health workers who attended the three study assessments‖
All: 1, 2, and 3 172 (64) 263 (91)
1 only 26 (10) 10 (3)
1 and 2 only 20 (7) 8 (3)
1 and 3 only 49 (18) 9 (3)
RDT = rapid diagnostic test.
*Data missing for four participants in Laos.
†Includes three who reported no formal education.
‡Data missing for 56 participants in Laos; for eight in Uganda.
§Data missing for 50 participants in Laos; for 11 in Uganda.
‖ In Laos, heavy flooding in the study area affected travel conditions and health worker attendance.
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participant was a community worker or clinic staff (P >
0.08), nor by how long the participant had been using RDTs
in routine patient care (P > 0.15). Overall, the proportion of
Ugandan participants who correctly performed all key steps
was significantly lower than the Lao participants (P < 0.05),
with the difference increasing over time. (Anecdotally, study
staff noticed that the Uganda study team tended to be
stricter in scoring than the Lao study team, so it may not be
appropriate to compare the two sites on this outcome).
Increasing health worker age was associated with an
increase in the odds of incorrectly filling the PCW dropper in
Ugandan participants at all assessments, with odds ratios
(ORs) varying between 1.03 (95% CI = 1.00–1.07) at the initial
assessment and 1.05 (95% I = 1.01–1.09) at the final assess-
ment. In Laos, age was only significant at the initial assess-
ment where the odds of incorrectly performing this step
increased 1.07 (95% CI = 1.02–1.13)-fold for each year
increase in participant age. There was no evidence of an age
effect in this step during the other assessments (P > 0.8)
in Laos.
Health workers had free access to the job aid while
performing the PCW under observation (Table 2). In Laos,
there was no difference in the frequency of referral to the job
aid between community workers and facility-based staff (P >
0.1); however, in Uganda, a higher proportion of community
workers referred to the job aid compared with facility-based
staff, particularly in the midpoint and study end assess-
ments (P < 0.01). In both countries at all assessments, there
was no significant association between referral to the job
aid during the assessment and correctly performing all six
key steps (P > 0.2).
At all three assessment points in both countries, ≥ 97% of
participants for whom data was recorded correctly read the
result of the RDT they prepared with a PCW, and ≥ 98%
gave a rational explanation for the result obtained. Errors in
reading included confusion between positive and negative
results or terminology, and failure to read faint lines as posi-
tive. Errors in explaining the result included both reporting
that a positive result indicated a poor-quality RDT stock,
and reporting that a negative or invalid result indicated a
good-quality RDT stock.
Interpretation of panels of reacted RDTs. Table 3 shows
health workers’ interpretation of reacted RDTs. At the study
midpoint, the proportion of health workers who gave correct
responses for all five RDTs was similar in both Laos and
Uganda (89%, P > 0.9). At the study end, the proportion
declined to 80% in Laos, whereas in Uganda, it increased to
93% (P < 0.001). Within each country, the change between
the midpoint and study end was not significant (P > 0.09). In
Laos, 75.3% of participants responded correctly for all five
RDTs on both occasions, 2.5% made errors on both occa-
sions, 14.6% were correct at the midpoint but made at least
TABLE 2
Positive control well performance checklist
Lao People’s Democratic Republic
Number (%)
Uganda
Number (%)
Study start
(N = 267)
Midpoint
(N = 192)
Study end
(N = 221)
Study start
(N = 290)
Midpoint
(N = 271)
Study end
(N = 272)
Looked at job aid ≥ 3 times while performing PCW 64/266 (24) 68 (35) 63/220 (29) 252/288 (88) 199/270 (74) 144/268 (54)
Looked at job aid 1 and 2 times while performing PCW 55/266 (21) 68 (35) 67/220 (30) 20/288 (7) 58/270 (21) 81/268 (30)
Did not look at job aid while performing PCW 147/266 (55) 56 (29) 90/220 (41) 16/288 (6) 13/270 (5) 43/268 (16)
Six key steps in PCW procedure Number (%) of health workers performing PCW procedure step correctly
Fill PCW dropper with water to mark 256 (96) 180 (94) 214/220 (97) 255 (88) 223 (82) 240 (88)
Empty water into PCW tube 262 (98) 183 (95) 218 (99) 286 (99) 262 (97) 252 (93)
Mix solution for 120 seconds 260 (97) 189 (98) 214 (97) 276 (95) 235 (87) 249 (92)
Transfer one drop PCW solution to correct RDT well 257 (96) 176 (92) 216 (98) 282/289 (98) 245 (90) 259 (95)
Put correct no. of buffer drops into correct well 261/266 (98) 187 (97) 217/220 (99) 278 (96) 260 (96) 258 (95)
Wait correct length of time before reading RDT result 264/265 (99.6) 189 (98) 217 (98) 282/289 (98) 267/270 (99) 258/270 (96)
All PCW preparation steps completed correctly 235/264 (89) 158 (82) 204/219 (93) 227/285 (80) 166/266 (62) 188/270 (70)
Read RDT result correctly 248/252 (98) 190 (99) 213/219 (97) 282/287 (98) 264/270 (98) 264/267 (99)
Give a correct/rational explanation for RDT result 253/256 (99) 190/191 (99) 214/219 (98) 281/284 (99) 265 (98) 261/266 (98)
PCW = positive control well; RDT = rapid diagnostic test. Health worker performance of PCW with RDT, observed by study staff, immediately after training at start of study, at study mid-
point 3 months after training, and at study end 6 months after training.
*Some observations missing, as indicated by insertion of denominators.
TABLE 3
PCW study participants’ interpretation of reacted RDTs, in response to question: “What would you do if you got this result while using a PCW
to check the RDT stock at your usual post of work?”*
Study midpoint Study end
True result of RDT
Correct proposed action†
True result of RDT
Correct proposed action†
Laos (N = 188) Uganda (N = 275) Laos (N = 216) Uganda (N = 277)
RDT 1 (positive) 181 (96) 266 (97) RDT 1 (positive) 210/215 (98) 276 (99.6)
RDT 2 (negative) 185/187 (99) 263 (96) RDT 2 (positive; faint line) 191/214 (89) 262 (95)
RDT 3 (invalid) 185/87 (99) 266 (97) RDT 3 (negative) 198/214 (93) 273 (99)
RDT 4 (negative) 183 (97) 264 (96) RDT 4 (invalid) 208/211 (99) 274 (99)
RDT 5 (positive) 171 (91) 269 (98) RDT 5 (negative) 199 (92) 273 (99)
Composite: all five responses correct 167/187 (89) 246 (89) Composite: all five responses correct 166/208 (80) 257 (93)
PCW = positive control wells; RDT = rapid diagnostic test.
*Some observations missing, as indicated by insertion of denominators.
†The correct action in response positive RDT results included continuing to use the stock of RDTs in routine patient care. The correct actions in response to negative or invalid RDT results
included repeating the PCW assessment with a second RDT from the same batch, calling the study team or supervisor for advice, or returning the stock of RDTs to a supervisor for replacement.
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one error at study end, and 7.6% made errors at the midpoint
but not at study end. In Uganda, these values were 83.4%,
1.9%, 5.7%, and 9.1%, respectively.
Errors were made in responses to positive, negative, and
invalid tests. However, most participants recognized invalid
tests as indicating the need for corrective action (97–99%
across both sites and evaluation points). A faint positive RDT
line presented at the study end presented a particular chal-
lenge (89% in Laos and 95% in Uganda responded correctly).
In Laos, there was no difference between the proportion
of community workers and clinic staff who correctly inter-
preted all five RDTs (P > 0.08). In contrast, in Uganda at the
study midpoint, more community workers correctly inter-
preted all five RDTs correctly (91%) than clinic staff (78%;
P = 0.022). In both countries, neither age nor time spent using
RDTs was associated with correct interpretation of RDTs (for
Laos, P > 0.2; for Uganda, P > 0.3). There was a positive
association between participants’ ability to correctly interpret
all five RDTs and to correctly perform the six key steps in
PCW preparation in both countries (analysis not shown).
Use of PCWs during routine clinical work. Records on
PCW use during routine work over the study period were
available from 221 (83% of total enrolled) to 275 (95%) par-
ticipants in Laos and Uganda, respectively (Table 4). The
number of PCWs used was not associated with the length
of time a health worker had been using RDTs (Spearman’s
rank correlation, P > 0.2).
In Laos, the most common reason given for performing a
PCW (481, 64%) was that the health worker had received a
new stock of RDTs. Performing a PCW because of concerns
about RDT results obtained with patients was not associated
in Laos with type of health worker (P = 0.40), but it was some-
what more likely among those who had been using RDTs for
a longer time (P = 0.06, OR = 1.01 [95% CI = 1.00–1.03]). In
Uganda, the primary reason given (1,049, 64%) was to check
the quality of existing RDT stocks. In Uganda, performing a
PCW because of concerns about patients’ RDT results was
associated with type of health worker (P < 0.001, 16% in clinic
staff versus 5% in community workers); here this reason was
somewhat less likely among health workers who had been
using RDTs for a longer time (P < 0.001, OR = 0.973 [95%
CI = 0.958–0.987]). Some Ugandan participants wrote in other
reasons for performing a PCW at their work site, including
practicing or “reminding myself” of the PCW procedure, test-
ing RDTs that were near or past their expiry date, or repeat-
ing a PCW test after an initial negative or invalid result.
Most records reported a correct action following use of a
PCW at the routine work site, based on the RDT result
obtained. In Laos, 97% of reported actions were correct. In
Uganda, some participants wrote their action on the record
form rather than ticking one of the choices on the form. In
these cases, it was necessary to interpret the meaning from
incomplete phrases and then categorize actions as “probably
correct” or “probably not correct”; thus, 94% of actions were
categorized as correct, and 99% as “correct or probably cor-
rect.” In Laos, clinic staff were slightly more likely than com-
munity workers to record a corrective action (99% versus
96%, P = 0.013), whereas in Uganda, there was no difference
(P > 0.9). There was no association between reporting a cor-
rect or probably correct action and the length of time
a health worker had been using RDTs in either country
(P > 0.5). Reported actions were more often correct if the
TABLE 4
Records of positive control well use kept by health workers at their work sites over 6-month study period
Feature
Lao People’s Democratic Republic*
Number (%)
Uganda
Number (%)
No. of health workers who brought PCW use records 221 (83) 275 (95)
Total no. of PCW use records received 762 1685
No. of PCWs used per reporting clinic staff: median, interquartile range, range 3, 2–5, 1–12 7, 5–12, 1–28
No. of PCWs used per reporting community worker: median, interquartile range, range 3, 2–4, 1–7 5, 4–7, 1–20
Recorded reason for performing a PCW (reasons are not exclusive)
“I received a new stock of RDTs” 481/747 (64) 4,83/1,645 (29)
“I wanted to check the quality of my RDTs” 239 (32) 1,049 (64)
“I have been getting many negative RDT results with patients” 16 (2) 74 (5)
“I’m not sure about the RDT results I am getting” 11 (1) 51 (3)
Other reasons 0 109 (7)
RDT result with PCW
Positive 711/738 (96) 1,510/1659 (91)
Negative† 24 (3) 142 (9)
Invalid† 3 (0.4) 7 (0.4)
Recorded action in response to PCW result
Continue using RDT stock with patients 688/723 (95) 1,426/1,651 (86)
Repeat PCW quality check with another RDT 32 (4) 209 (13)
Stop using RDT stock and call supervisor and/or study team 2 (0.3) 31 (2)
“Correct” action based on recorded RDT result 685/709 (97) 1,533/1,626 (94)
“Probably correct” action* — 77 (5)
“Correct” or “probably correct” action* — 1610 (99)
“Incorrect” action recorded based on recorded RDT result 24/709 (3) 11 (1)
“Correct” action if RDT recorded as positive 667/683 (98) 1,411/1,488 (95)
“Incorrect” action if RDT recorded as positive 16 (2) 0
“Correct” action if RDT recorded as negative or invalid 18/26 (69) 122/138 (88)
“Incorrect” action if RDT recorded as negative or invalid 8 (31) 11 (8)
PCW = positive control wells; RDT = rapid diagnostic test.
*Many Ugandan participants wrote their action on the record form rather than using the tick boxes. In some cases, this necessitated interpreting the intended action from incomplete
phrases, which resulted in categorization as “probably correct” or “probably not correct.”
†All negative or invalid RDT results that were reported to study staff were followed up immediately by telephone. In all cases, when the health worker was verbally assisted to repeat the
assessment with the correct procedure using a second RDT from her/his stock, the result was positive. There were no confirmed cases of poor-quality RDT stocks identified during the study.
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RDT result obtained with a PCW was positive than if the
result was negative or invalid.
Impact of PCW availability on RDT use. In Laos, when
aggregated data from clinic staff were compared between
the PCW and control provinces, there were significant dif-
ferences in the proportion of patients receiving an RDT in
Salavan versus Sekong (P < 0.001), and also between
patient age groups within each province (P < 0.001; Table 5).
However, there was no difference in the rate of RDT use
between the pre-PCW period (December 2012–March 2013)
and the PCW period (April–November 2013) in either province
(P > 0.6). In Salavan, the relative risk of receiving antimalarial
treatment in a health facility, adjusted for the number of posi-
tive RDTs, was 1.04 (95% CI = 1.03–1.06) times higher after
PCW introduction (April–November) compared with before
PCW introduction (December–March) (P < 0.001; Table 5).
No change in treatment rates by clinic staff were detected
in Sekong between these same periods (P = 0.14). Data for
community workers in Salavan and Sekong list only patients
who were tested with RDTs (i.e., the proportion tested was
100%) and report that 100% of RDT-positive patients were
treated with artemisinin-based combination therapy; no fur-
ther analysis is possible.
In Uganda, individual patient data were compared between
the PCW and control districts, stratified for management by
clinic staff and community workers. Clinic staff performed a
total of 60,144 RDTs for 87,893 patients. The proportion of
patients tested was significantly higher in the control district
(Kyankwanzi) than in Kiboga, and was also significantly
higher in the pre-PCW period in both districts (Table 6). In the
control district, the odds of receiving antimalarial treatment of
positive RDT results increased significantly in the second
part of the study (OR = 1.27, 95% CI = 1.02–1.58, P =
0.033). In Kiboga, none of the factors tested was a signifi-
cant predictor of antimalarial treatment of RDT-positive cases
(P > 0.2) with 96.7% receiving treatment. A lower proportion
of RDT-negative patients received antimalarial treatment in
Kiboga District than in the control area. In Kiboga, after intro-
duction of PCWs, antimalarial treatment of RDT-negatives
increased for young children but decreased for older patients;
whereas in the control district, treatment of negatives
increased for all age groups over the same time period.
Records for 39,882 patients seen by community health
workers in Uganda were analyzed (Table 7). The odds of
conducting an RDT were 1.61 (95% CI = 1.49–1.74) times
higher for the post-PCW period compared with the pre-
PCW period in both districts. Patients with positive RDT
results had twice the odds of receiving antimalarial treat-
ment in Kiboga compared with Kyankwanzi (OR = 2.20, 95%
CI = 1.49–3.27), although both districts treated over 99% of
RDT-positive cases with antimalarials (Table 7). In Kiboga,
the proportion of RDT-negative patients treated with an anti-
malarial decreased from 35.4% before PCW introduction to
23.3% afterward. In Kyankwanzi, the proportion increased
from 20.9% pre-PCW to 60.3% over the same time period.
Qualitative findings on health workers’ perceptions
of PCWs. In Laos, 84 participants (60% community workers)
took part in 11 semistructured interviews and 11 FGDs. In
Uganda, 119 participants (76% community workers) partici-
pated in 29 interviews and 11 FGDs. A more extensive analy-
sis of qualitative data will be reported elsewhere; a summary
of key findings is presented herein.
Most health workers reported that difficulties in perform-
ing the PCWs were generally minor and became easier with
training and experience. Several noted the challenge posed
by the appearance of faint—rather than clearly visible—
RDT test lines with PCW use (Box 1, Quote 1 [Q1]).
In general, PCWs were discussed by health workers as a
way to confirm RDT quality and restore confidence in RDT
results in some situations where doubts existed. For example,
TABLE 5
EMMs for RDT, results, and antimalarial treatment in Lao People’s Democratic Republic health facilities with and without PCWs*
Province
Patient age
(years)
EMM for proportion of patients
receiving RDT (95% CI*)
EMM for proportion of patients
RDT-positive (95% CI*)
EMM for proportion of RDT-positive patients
receiving antimalarial treatment (95% CI)
Sekong (control) 0–5 0.331 (0.288–0.380) 0.184 (0.115–0.296) 0.972 (0.955–0.988)
> 5 0.420 (0.384–0.460) 0.147 (0.119–0.181)
Salavan (PCW) 0–5 0.397 (0.352–0.447) 0.184 (0.115–0.296) Pre-PCW: 0.934 (0.922–0.947)
> 5 0.504 (0.480–0.529) 0.308 (0.286–0.332) Post-PCW: 0.974 (0.965–0.982)
CI = confidence interval; EMM = estimated marginal mean; PCW = positive control wells; RDT = rapid diagnostic test.
*EMMs are presented individually for groups where significant differences were detected (P < 0.05), and are merged across categories when no significant difference between categories
was detected.
TABLE 6
EMMs for RDT, results, and antimalarial treatment in Uganda health facilities with and without PCWs*
District Period
Patient age
(years)
EMM for proportion of
patients receiving
RDT (95% CI*)
EMM for proportion of
patients RDT-positive
(95% CI*)
EMM for proportion of RDT-positive
patients receiving antimalarial
treatment (95% CI*)
EMM for proportion of
RDT-negative patients receiving
antimalarial treatment (95% CI*)
Kyankwanzi
(control)
Pre-PCW < 5 0.858 (0.850–0.865) 0–5 years: 0.403 (0.394–0.412)
> 5 years: 0.351 (0.345–0.357)
0.975 (0.971–0.978) 0.302 (0.289–0.316)
≥ 5 0.830 (0.824–0.836) 0.196 (0.188–0.205)
Post-PCW < 5 0.725 (0.715–0.735) 0.980 (0.977–0.983) 0.431 (0.414–0.449)
≥ 5 0.734 (0.728–0.740) 0.340 (0.331–0.350)
Kiboga
(PCW)
Pre-PCW < 5 0.650 (0.634–0.665) 0.470 (0.458–0.482) 0.967 (0.962–0.971) 0.024 (0.017–0.034)
≥ 5 0.546 (0.535–0.557) 0.047 (0.039–0.056)
Post-PCW < 5 0.545 (0.531–0.559) 0.571 (0.562–0.579) 0.056 (0.044–0.072)
≥ 5 0.525 (0.518–0.533) 0.019 (0.015–0.023)
CI = confidence interval; EMM = estimated marginal mean; PCW = positive control wells; RDT = rapid diagnostic test.
*EMMs are presented individually for groups where significant differences were detected (P < 0.05), and are merged across categories when no significant difference between categories
was detected.
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BOX 1
Representative quotes from health worker participants in focus
group discussions and semistructured interviews
Quote 1: Q: Which steps of PCWs are most difficult? A1: It’s
difficult only when we stir it, sometimes we miscounted. A2:
Sometimes the line was faded, which makes it difficult to read.
Q: Was it difficult to read? A1: Yes, the line color was faded but
it was readable. A2: The line was not clear, I didn’t know what to
say. 08-CW-FGD/Laos
Quote 2: There are times when you get patients that clinically
look sick but when you test the RDT shows negative results, so
you begin doubting your results and then use the PCW, if it
gives you positive results then you get sure that they are still
good. 03-CS-FGD/Uganda
Quote 3: Before PCWs came I did not trust them because they
could bring a convulsing child and the test turns out to be
negative. In that situation you write a referral form while
questioning the RDT quality. Sometimes you find that the child
has high fever and you expect it to be malaria but you find it
negative. So at first we had doubts . . . until PCWs were brought,
so we are now sure of what we do. 08-CW-FGD/Uganda
Quote 4: Whenever they doubt our RDTs we tell them that we
have something, which helps us to check the quality of RDTs if
they are still good. So after checking them if they give us
negative results then that means you probably have cough, flu
or something else, not malaria, so that is what we should treat
because it’s the cause of the fever. 02-CS-FGD/Uganda
Quote 5: When you begin doubting you don’t tell the patient but
you perform a PCW and when you get positive you know that
your RDTs are good. 04-CS-FGD/Uganda
Quote 6: First of all the PCW has removed that doubt from the
health worker so the only task is to convince the patient to accept
the negative result. 03-CS-FGD/Uganda
Quote 7: When I get numerous consecutive negatives and also
when I get many positives still I lose trust in [RDT results]. 08-CS-
SSI/Uganda
Quote 8: I had to do the blood testing twice. If the results were
still negative then people were not infected with malaria,
because there are many diseases that have signs and
symptoms like malaria. 05-CS-FGD/Laos
Quote 9: I used to doubt the negative test results when there
were many negative results because previously we didn’t have
positive control wells. 05-CS-FGD/Laos
Quote 10: Before PCWs came we used to treat without caring
about whether RDTs are good or not, they could show
constant results e.g. negative or positive yet they might have
been wrong. But when PCWs came, I now feel confident of
what I am using. 11-CW-FGD/Uganda
Quote 11: A1: No, we can test the RDT by shaking the
desiccant and also the expiry date. A2: But that does not test
the quality, it only shows that it is in normal working condition,
but doesn’t show the quality. 04-CS-FGD/Uganda
Quote 12: Now that beats my understanding because if these
RDTs have expired and then you test them with the PCW and
get positive results why don’t we use them? [laughter from other
participants] Because they say PCWs check the quality of RDTs,
so then if they are saying that the quality is good, why don’t we
then use them? 04-CS-FGD/Uganda
Quote 13: Q: If PCW performance shows a negative or bad RDT,
do you trust this result? A1: No, I don’t trust [it]. There might be
some mistakes in the PCW performance. [laughter from other
participants] A2: I think that the RDT box might be of bad quality.
A3: If [the RDTs] are kept in a good place and are not expired,
I probably think that the PCW kit is bad. 06-CW-FGD/Laos
(continued)
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when health workers encountered a discrepancy between
their own clinical impression (that a patient had malaria) and
a negative RDT result, PCW use was reported to help resolve
the uncertainty (Q2 and Q3). Some health workers mentioned
their use of PCWs to patients as a way of convincing them
that RDT results were reliable (Q4); but more often health
workers did not mention PCWs to patients as they believed
such information was too technical for patients to under-
stand, or was relevant only for health workers (Q5 and Q6).
In both Laos and Uganda, among both clinic staff and
community workers, one of the most frequently mentioned
reasons for health workers to doubt RDT results was
obtaining “too many” consecutive similar results when testing
patients, especially consecutive negative results (Q7). Previ-
ously, typical reactions to this concern might have been either
to repeat a patient’s test to confirm the result (Q8), or to disre-
gard a negative result and treat empirically with antimalarials.
PCWs appeared to have some capacity to restore trust for
health workers faced with serial negative results (Q9).
Before PCW introduction most health workers recognized
that RDTs could be of poor quality or faulty. However, for
some, the introduction of PCWs appeared to confirm this
possibility (Q10). Similarly, health workers had previously
been trained to check RDTs’ expiration date and desiccant
packet as a means of quality control; whereas PCWs intro-
duced a new quality-control option that needed to be trans-
lated into understanding and practice (Q11). However, the
availability of multiple quality-control indicators also led some
health workers to experiment with expired RDTs (Q12).
Finally, some participants questioned whether PCWs could
also be of poor quality (Q13–15).
DISCUSSION
PCWs have been developed as a point-of-care quality-
control tool to monitor the validity of malaria RDTs. This study
introduced PCWs for use by front-line health workers in Laos
and Uganda. In both settings, after a half-day training, most
participating clinic staff and community health workers were
able to correctly perform PCWs and interpret results, and to
maintain these skills over the 6-month study duration. When
PCWs were provided at health-care sites for routine use, most
participants recorded correct use of PCWs and appropriate
actions based on results. There were both quantitative and
qualitative evidences in some settings that PCWs improved
health workers’ confidence in RDT results for patient care.
For PCW use to be effective, users must correctly perform
PCW steps and interpret RDTs, and take the appropriate
action based on RDT results. PCW steps that appeared most
challenging included obtaining and transferring the correct
volumes of water and PCW solution, and stirring the solution
for the recommended length of time. Similar difficulties with
transferring small, precise volumes have been reported in
RDT training efforts, especially among lower-level health
workers.11,22,23 Significant errors in volume transfer and stir-
ring could lead to too little antigen reaching the RDT, which
may result in a “false-negative” result and a false impression
that the RDT is defective. Pending any simplification of the
PCW format, careful training and supervision may reduce this
risk. PCW validation and stability studies are ongoing, and
final technical specifications will be reported elsewhere.
Anecdotally, study team observers noted that poor eye-
sight appeared to contribute to some participants’ difficulties
preparing PCWs; visual acuity was not assessed systemati-
cally, but health worker age (which may be a proxy in some
cases) was associated with incorrectly filling the PCW drop-
per particularly in Uganda. Poor vision may also influence
health workers’ interpretation of RDT results, especially in the
case of faint test lines.24,25 The amount of antigen in a PCW
is intended to differentiate between a valid RDT, and one that
cannot detect the lower limits of most clinically significant
parasitemia (∼200 parasites/μL)20; therefore, PCW solution
typically produces a faint RDT test line on a working RDT.
Both quantitative and qualitative data indicate that some study
participants were uncertain of how to interpret faint test lines,
although PCW training had stated that a line of any intensity
should be considered positive. Indeed, some health workers
intentionally applied more than the recommended volume of
PCW solution to achieve a stronger test line.
In general, the few health workers who found one aspect of
PCWs challenging (e.g., preparation steps) also made errors
with others (e.g., interpretation). Therefore, future PCW imple-
mentation programs could plan to identify health workers
who may benefit from extra training assistance. The training
materials and pictorial guide designed for this study appeared
appropriate for the participating front-line health workers. No
significant patterns were identified between PCW perfor-
mance and length of experience with RDTs. Also, no sub-
stantial differences between clinic staff and community
workers were seen in ability to correctly perform, interpret
and use PCWs. In many settings, community health workers
(village health volunteers) are tasked with managing malaria
with or without RDTs.26–28 This study provides reassurance
that PCWs may also be integrated into such programs.
During the study, all negative or invalid RDT results
obtained with PCWs were immediately followed up by tele-
phone with the reporting health worker. Study staff verbally
assisted the health worker to repeat the PCW assessment
with another RDT from the same stock. In all cases, the
repeat test result was positive; there were no confirmed
cases of poor-quality RDT stocks identified during the
study. In other settings, where poor-quality RDTs may be
more common, extra attention may be required to ensure
that functional reporting and response systems are in place
to handle health workers’ reports in a timely way.
Where data are available to assess the effect of PCWs on
RDT use and patient management, these appear to be neu-
tral or, in some cases, possibly beneficial. In Laos, anti-
malarial treatment of RDT-positive patients rose after PCW
introduction, but it is unclear whether this effect was due to
PCWs or to other factors. In Uganda, after PCW introduc-
tion, use of RDTs dropped among clinic staff in both the
PCW and control area, whereas it rose among community
Quote 14: Q: If we are certain of the two performances, why do
you think the results are different? A1: I have to think of PCW,
it might have deteriorated. Q: How can a PCW deteriorate?
A1: PCWs [also] have a shelf life. A2: It might be due to the water
used, it is very difficult to find clean water. 05-CS-FGD/Laos
Quote 15: A1: But I have a question: How do you test the PCWs
to identify their quality? A2: That one has not yet come.
[laughter from other participants] 04-CS-FGD/Uganda
BOX 1
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workers in both areas; no clear explanation (e.g., fluctuations
in RDT supply) for these differences was identified. There
were no substantial changes in antimalarial treatment of
RDT-positives in Uganda. However, after PCW introduction,
antimalarial treatment of RDT-negative patients declined sig-
nificantly for patients older than 5 years managed by clinic
staff, and for all patients seen by community workers; this
occurred in the face of large increases over the same time
period in the control district (and for young children managed
by clinic staff in the PCW district). Coupled with qualitative
data indicating that PCWs boosted many health workers’
confidence in RDT results, these findings suggest that PCWs
may help to address the persistent problem of unnecessary
antimalarial treatment of test-negative patients.29,30
At the study end, health workers were asked about their
recommendations for future implementation of PCWs (data
not shown). Around three-quarters of Lao health workers
and two-thirds in Uganda suggested that PCWs should be
packaged separate from RDTs to avoid waste and to avoid
the risk of exposing both RDTs and PCWs to adverse
transport and storage conditions. Health workers who
favored packaging PCWs and RDTs together cited conve-
nience as a rationale. Most participants recommended that
PCWs should be implemented alongside clear guidelines
for when to use them (rather than leaving health workers
to design their own schedules).
This study has several limitations. Health workers knew
that they were participating in research, so the Hawthorne
effect may have influenced their PCW performance under
observation as well as records kept during routine work.
Keeping written records appeared to be challenging for
some study participants, especially in Laos where some
records with missing data were excluded from analysis. This
observation reflects the challenges of conducting research
among front-line health workers in malaria-endemic areas
(and also highlights one of the challenges encountered
when health-care systems must rely on staff with limited
education). More PCWs were used per health worker in
Uganda than in Laos, perhaps at least in part because the
RDTs in the Uganda study area were more freely available.
Patient-level data on RDT use and antimalarial prescribing
was only available in Uganda, so the effects seen there
could not be compared with data from Laos.
The need for malaria RDT quality-control strategies,
appropriate for routine health-care settings in endemic areas,
is well recognized.10–13 Alternatives such as microscopy and
molecular tools as reference tests use different biological
parameters, do not provide real-time information and are
generally not feasible for most programs. Some RDT manu-
facturers sell positive controls as a separate catalogue item,
but these require a cold chain, are product specific, and
some are not for single use. Alternatively, researchers have
evaluated dried blood containing cultured Plasmodium
falciparum parasites at specific densities as a positive control
for RDTs, but this approach does not generate consistently
reproducible antigen concentrations; in addition, the need for
cultured parasites, potential for degradation under field con-
ditions, and multiple rehydration steps limit their use.14,16 If
technical specifications are met, including stability under typ-
ical storage conditions,15 PCWs based on dried recombinant
antigen, such as the prototype introduced in this study,
appear best suited for wide-scale implementation.
CONCLUSIONS
This is the first study to introduce PCWs for malaria RDTs
for routine use by front-line health workers in endemic areas.
Over the 6-month study period, health workers were able to
correctly prepare and interpret PCW results to identify and
report poor-quality RDTs. Results suggest that PCWs may
improve health workers’ confidence in RDT results, and
reduce antimalarial overtreatment of RDT-negative patients.
Data collected are intended to guide eventual implementation
strategies for PCWs that meet technical specifications.
Future work should refine these strategies for various con-
texts, and evaluate the longer term impact of PCWs on
health worker behaviors, patient management, and cost-
effectiveness of RDT use. Lessons learned from malaria RDT
and PCW implementation may be valuable in introducing
other point-of-care diagnostic and quality-control tools.
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